Latham & Watkins Advises B-Flexion on Sale of Affidea Group

London team advises on sale of Europe’s largest provider of diagnostic imaging, outpatient, and cancer care services.

April 19, 2022

Latham & Watkins has advised B-Flexion, a private investment firm, on the sale of Affidea Group to Groupe Bruxelles Lambert.

Affidea is the largest European provider of advanced diagnostic imaging, outpatient, and cancer care services. Under B-Flexion’s ownership, the company has grown from 120 to over 320 centres across 15 European countries. With more than 1300 radiologists in its network, Affidea provides services to more than ten million patients annually.

The Latham team was led by London corporate partner Mike Turner, with associates Katie Kaplucha, Daria Les, and Hadi Najem. Advice was also provided on antitrust matters by London partner Jonathan Parker, with associates Anuj Ghai, James Mathieson, and Stephanie Adams; on employment matters by London partner Sarah Gadd; on finance matters by London partner Fergus O’Domhnaill, with associate Lewis Atherton; and on tax matters by London partner Karl Mah, with counsel James Leslie and associate Sam Duncan.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.